Wardwizard healthcare Limited's Board of Directors held a meeting on February 12, 2026, to discuss significant compliance issues related to SEBI's Insider Trading Regulations. The company addressed non-compliance matters concerning SDD (Structured Digital Database) requirements that affected three consecutive quarters.

Compliance Issues Identified

The board discussed non-compliance with provisions of Regulation 3(5) and/or Regulation 3(6) of SEBI (Prohibition of Insider Trading) Regulations, 2015. The compliance issues specifically related to the following quarters:

Nature of Non-Compliance

According to the board's statement, the company was required to submit SDD certificates duly certified by a Practicing Company Secretary as per Exchange Circular No. 20241018-44 dated October 18, 2024. However, the company inadvertently submitted SDD certificates without the required Practicing Company Secretary certification for all three quarters.

The board acknowledged this inadvertent omission and expressed sincere regret for the oversight. The directors emphasized that this was an unintentional error rather than a deliberate violation of regulatory requirements.

Remedial Actions Taken

The company's secretarial team has implemented corrective measures to address the compliance gaps:

• Resubmitted SDD certificates with proper Practicing Company Secretary certification on December 1, 2025
• Additional submission made on January 3, 2026
• All three affected quarters (March 31, 2025, June 30, 2025, and September 30, 2025) have been addressed

Board's Commitment to Compliance

The Board of Directors made several commitments regarding future compliance:

• Acknowledged the importance of adhering to all regulatory requirements
• Assured that such incidents will not recur in the future
• Committed to taking all necessary steps to ensure adherence to applicable rules and regulations
• Emphasized maintaining the highest standards of compliance
• Expressed commitment to preserving good relationships with the exchange

The board's response demonstrates the company's recognition of the seriousness of regulatory compliance and its commitment to maintaining proper corporate governance standards going forward.

Wardwizard Healthcare Limited (formerly known as Ayoki Mercantile Limited) has announced significant changes to its key managerial personnel, including the appointment of a new Chief Executive Officer (CEO). The company's Board of Directors approved these changes in a meeting held on November 14, 2025.

Key Management Changes

The company has made the following appointments, effective November 14, 2025:

New CEO Appointment

The most notable change is the appointment of Mr. Yuvraj Priyadarshi as the new Chief Executive Officer. Mr. Priyadarshi brings a wealth of experience to the role:

Educational Background

• Doctor of Optometry (O.D.)
• Master of Science in Vision Science (M.S.V.S.)
• MBA in Hospital Management
• Ph.D.

Professional Experience

• 9 years with WHO East Africa in Public Health
• 2 years as COO of Mombasa Eye Hospital (East Africa)
• Founder & MD of AMAX HSEQ Pvt. Ltd. (Health, Safety & Environment)
• Founder & MD of AMAX Medical Center
• Director of AMAX Eye Hospital
• Director of TITAN Eye + (Bharuch & Surat)

Mr. Priyadarshi also has a strong social profile, serving as the Managing Trustee of Hope HE (Health & Education) Trust and holding leadership positions in Rotary Club.

Committee Restructuring

The Board has also approved the reconstitution of the Stakeholder Relationship Committee. The new composition is as follows:

These changes reflect Wardwizard Healthcare's commitment to strengthening its leadership team and corporate governance structure. The company aims to leverage the diverse experience of its new appointees to drive growth and enhance stakeholder value.

Investors and stakeholders can find more details about these changes on the company's website at https://www.ayokimerchantile.com .